CELF2 and acute myeloid leukemia: Since FAT10-mTORC1 signaling pathway plays a central role in the pathogenesis of Celf2 KO + MA9 AML, we sought to determine whether dual inhibition of mTORC1 and MA9 pathways would be beneficial for Celf2 KO + MA9 AML mice.